Диссертация (1173261), страница 20
Текст из файла (страница 20)
–2016 Feb. – №55. – P. 108–12.179. Spatt, J. Austrian Section of the International League Against EpilepsyPredictors for negative attitudes toward subjects with epilepsy: a representative surveyin the General Public in Austria. / J. Spatt, G. Bauer, C. Baumgartner, M. Feucht, M.Graf, B. Mamoli, E. Trinka // Epilepsia. – 2005. – №46(5). – P. 736–742.180. Sun, F.T. Responsive cortical stimulation for the treatment of epilepsy. /F.T. Sun, M.J. Morrell, R.E. Wharen // Neurotherapeutics. – 2008 Jan. – №5(1). – P.68–74.181. Szaflarski, J.P. Seizure disorders, depression, and health–related quality oflife. / J.P. Szaflarski, M. Szaflarski. // Epilepsy Behav.
– 2004. – №5. – P. 50–7.182. Szaflarski, M. Quality of life in medication–resistant epilepsy: the effectsof patient's age, age at seizure onset, and disease duration. / M. Szaflarski, J.M.Meckler, M.D. Privitera, J.P. Szaflarski // Epilepsy Behav. – 2006 May. – №8(3). – P.547–51.183. Tang, W.K. Anxiety symptoms in patients with frontal lobe epilepsy versusgeneralized epilepsy. / W.K Tang, S. Gabor, K.S. Ungvarib, C.
Wong, P. Kwanc //Seizure. – 2012 July. – Volume 21. – Issue 6. – P. 411–486.184. Tao, K. The comorbidity of epilepsy and depression: diagnosis andtreatment. / K. Tao, X. Wang // Expert Rev Neurother. – 2016 Nov. – №16(11). – P.1321–1333.185. Thomas, S.V. Frequent seizures and polytherapy can impair quality of lifein persons with epilepsy. / S.V. Thomas, S. Koshy, S.C. Nair, S.P.
Sarma // NeurolIndia. – 2005. – №53. – P. 46–50.186. Tomson, T. Who to target in sudden unexpected death in epilepsyprevention and how? Risk factors, biomarkers, and intervention study designs. /125T. Tomson, R. Surges, R. Delamont, S. Haywood, D.C. Hesdorffer. // Epilepsia. –2016.
– №57. – P. 4–16.187. Tonekaboni, S.H. Neurocognitive effects of phenobarbital discontinuationin epileptic children. / S.H. Tonekaboni, M. Ghazavi, P. Karimzadeh, F. Mahvelati, M.Ghofrani. // Epilepsy Behav. – 2006 Feb. – №8(1). – P. 145–8.188. Trimble, M.R. Epilepsy and Quality of Life. / M.R. Trimble, W.E. Dodson// Neurosurgery. – 1995 July. – Vol 37. – Issue 1. – P.
158.189. Usui, N. Focal semiologic and electroencephalographic features in patientswith juvenile myoclonicepilepsy. / N. Usui, P. Kotagal, R. Matsumoto [et al.] //Epilepsia. – 2005. – Vol. 46. – P. 1668–1676.190. Vendrame, M. Insomnia and Epilepsy: A Questionnaire–Based Study. / M.Vendrame, B. Yang, S. Jackson, S.H.
Auerbach //J Clin Sleep Med. – 2013 Feb. –№9(2). – P. 141–146.191. Vignatelli, L. Excessive daytime sleepiness and subjective sleep quality inpatients with nocturnal frontal lobe epilepsy: a case–control study. / L. Vignatelli, F.Bisulli, I. Naldi, S. Ferioli, F. Pittau, F. Provini, G. Plazzi, R. Vetrugno, P. Montagna, P.Tinuper // Epilepsia.
– 2006. – №47 (Suppl 5). – P. 73–7.192. Vibha, P. Quality of life (QOL) and marital adjustment in epilepsy andcomparisons with sychiatric illnesses. / P. Vibha, S. Saddichha, S. Akhtar. //International Journal of Psychosocial Rehabilitation. – 2010. – №14(2). – P. 105–12.193. Wagner, A.K. The health status of adults with epilepsy compared with thatof people without chronic conditions. / A.K. Wagner, K.M. Bungay, M. Kosinski, [etal.] // Pharmacotherapy. – 1996. – №16. – P. 1–9.194. Wang, W.Z.
Evaluation of the efficacy of phenobarbital in treatment ofepilepsy in rural areas: study of 2455 patients in rural China. / W.Z. Wang, J.Z. Wu,X.Y. Dai, T.P. Wang, B. Yang, G.Y. Ma, C.L. Yuan, Z. Hong, D.H. Zhao // ZhonghuaYi Xue Za Zhi. – 2006 May. – №86(19). – P. 1297–300.195.
Wakamoto, H. Long term medical, educational, and social prognoses ofchildhood onset epilepsy: a population based study in a rural district of Japan. / H.126Wakamoto, H. Nagao, M. Hayashi, T. Morimoto. // Brain Dev. – 2000. – №22 – P.246–255.196. Wesnes, K.A. The cognitive and psychomotor effects of remacemide andcarbamazepine in newly diagnosed epilepsy. / K.A. Wesnes, C.
Edgar, A.D. Dean, S.J.Wroe // Epilepsy Behav. – 2009 Mar. – №14(3). – P. 522–8.197. Whatley, A.D. Examining the relationships of depressive symptoms,stigma, social support and regimen–specific support on quality of life in adult patientswith epilepsy. / A.D. Whatley, C.K.
Dilorio, Yeager // Health Educ. Res. – 2010 Aug. –№25(4). – P. 575–584.198. Wheless, J.W. Treatment of pediatric epilepsy: European expert opinion,2007 / J.W. Wheless, D.F. Clarke, A. Arzimanoglou, D. Carpenter // Epileptic Disord. –2007. – Vol. 9. – P. 353–412.199. Wildrick, D. Quality of life in children with well–controlled epilepsy. / D.Wildrick, S.
Parker–Fisher, A. Morales // J Neurosci Nurs. – 1996 Jun. – №28(3). – P.192–8.200. Wirrell, E.C. A Population–Based Study of Long–term Outcomes ofCryptogenic Focal Epilepsy in Childhood: Cryptogenic Epilepsy is NOT ProbablySymptomatic Epilepsy. / E.C Wirrell, B.R. Grossardt, E.L. So, K.C. Nickels //Epilepsia. – 2011 Apr.
– №52(4). – P. 738–745.201. Wolf, P. Regional manifestation of idiopathic epilepsy. / P. Wolf, S.Berkovic, P. Genton, C. Binnie, V.E. Anderson, A. Draguhn // Epileptic seizures andsyndromes. – John Libbey. – London. – 1994. – P. 265–281.202. World Health Organization (WHO) Epilepsy in the WHO EuropeanRegion. Fostering Epilepsy Care in Europe. ILAE\IBE\WHO Global Campaign AgainstEplepsy, SEIN, Hoofddorp.The Netherlands, 2007.203. World Health Organization (WHO). Atlas–Epilepsy Care in the World,WHO Geneva, 2005.204. World Health Organization (WHO). Global burden of epilepsy and needfor a coordinated action at the country level to address its health, social and publicknowledge implications.
Resolution approved by the WHO Executive Board,127http://apps.who.int/gb/ebwha/pdf_files/EB136/B136_R8–en.pdf Accessed february 12,2015.205. Wrench, J.M. Hippocampal volume and depression: insights from epilepsysurgery. / J.M. Wrench, S.J. Wilson, P.F. Bladin, [et al.] // J Neurol NeurosurgPsychiatry. – 2009. – №80.
– P. 539–44.206. Yazdi, Z. Prevalence of Sleep Disorders and their Effects on Sleep Qualityin Epileptic Patients. / Z.Yazdi, K. Sadeghniiat–Haghighi, S.Naimian, M. Ali Zohal, M.Ghaniri. // Basic Clin Neurosci. – 2013 Winter. – №4(1). – P. 36–41.207. EuropeanMedicinesAgency,octoberPharmacovigilance Risk Assessment Committee (PRAC).2014EMA/686022/2014.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
